<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="modify">
            <roleset id="modify.01" name="" wordnet="3">
                <roles>
                    <role n="0" descr="agent, cause of transformation&#x0A;" />
                    <role n="1" descr="thing changing&#x0A;" />
                    <role n="2" descr="method&#x0A;" />
                    <role n="3" descr="consequence&#x09;&#x09;&#x09;&#x09;// secondary predication //&#x0A;" />
                </roles>
                <example src="ARCHIVE" no="0">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests a potential mechanism for modifying the EZH1 protein in the conserved C-terminal domain.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="ARCHIVE" no="1">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests a potential mechanism modifying the EZH1 protein in the conserved C-terminal domain.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="ARCHIVE" no="2">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests a potential mechanism that can modify the EZH1 protein in the conserved C-terminal domain.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="ARCHIVE" no="3">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests a potential mechanism that has the ability to modify the EZH1 protein in the conserved C-terminal domain.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="ARCHIVE" no="4">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests a potential mechanism that is able to modify the EZH1 protein in the conserved C-terminal domain.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="ARCHIVE" no="5">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests a potential mechanism that is observed to modify the EZH1 protein in the conserved C-terminal domain.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="ARCHIVE" no="6">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests a potential mechanism that may have modified the EZH1 protein in the conserved C-terminal domain.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="ARCHIVE" no="7">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests a potential mechanism that might have modified the EZH1 protein in the conserved C-terminal domain.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="ARCHIVE" no="8">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests a potential mechanism that modifies the EZH1 protein in the conserved C-terminal domain.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="ARCHIVE" no="9">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests a potential mechanism to modify the EZH1 protein in the conserved C-terminal domain.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="ARCHIVE" no="10">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests a potential mechanism which can modify the EZH1 protein in the conserved C-terminal domain.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="ARCHIVE" no="11">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests a potential mechanism which has modified the EZH1 protein in the conserved C-terminal domain.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="ARCHIVE" no="12">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests a potential mechanism which is able to modify the EZH1 protein in the conserved C-terminal domain.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="ARCHIVE" no="13">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests a potential mechanism which is observed to modify the EZH1 protein in the conserved C-terminal domain.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="ARCHIVE" no="14">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests a potential mechanism which may have modified the EZH1 protein in the conserved C-terminal domain.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="ARCHIVE" no="15">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests a potential mechanism which might have modified the EZH1 protein in the conserved C-terminal domain.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="ARCHIVE" no="16">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests a potential mechanism which modified the EZH1 protein in the conserved C-terminal domain.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="ARCHIVE" no="17">
                    <text>P.falciparum can be modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="18">
                    <text>P.falciparum can be notably modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="19">
                    <text>P.falciparum could be modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="20">
                    <text>P.falciparum could be notably modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="21">
                    <text>P.falciparum could have been modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="22">
                    <text>P.falciparum could have been notably modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="23">
                    <text>P.falciparum has been modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="24">
                    <text>P.falciparum has been notably modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="25">
                    <text>P.falciparum has the ability to be modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="26">
                    <text>P.falciparum has the ability to be notably modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="27">
                    <text>P.falciparum has the probability of being modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="28">
                    <text>P.falciparum has the probability of being notably modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="29">
                    <text>P.falciparum is able to be modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="30">
                    <text>P.falciparum is able to be notably modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="31">
                    <text>P.falciparum is being modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="32">
                    <text>P.falciparum is being notably modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="33">
                    <text>P.falciparum is modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="34">
                    <text>P.falciparum is notably modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="35">
                    <text>P.falciparum is observed to be modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="36">
                    <text>P.falciparum is observed to be notably modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="37">
                    <text>P.falciparum may be modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="38">
                    <text>P.falciparum may be notably modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="39">
                    <text>P.falciparum may have been modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="40">
                    <text>P.falciparum may have been notably modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="41">
                    <text>P.falciparum might be modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="42">
                    <text>P.falciparum might be notably modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="43">
                    <text>P.falciparum might have been modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="44">
                    <text>P.falciparum might have been notably modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="45">
                    <text>P.falciparum was able to be modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="46">
                    <text>P.falciparum was able to be notably modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="47">
                    <text>P.falciparum was modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="48">
                    <text>P.falciparum was notably modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="49">
                    <text>P.falciparum was observed to be modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="50">
                    <text>P.falciparum was observed to be notably modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="51">
                    <text>P.falciparum will be modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="52">
                    <text>P.falciparum will be notably modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="53">
                    <text>P.falciparum would be modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="54">
                    <text>P.falciparum would be notably modified genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="55">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ can modify or in some way direct OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="56">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ can significantly modify or in some way direct OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="57">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ could have modified or in some way directed OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="58">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ could have significantly modified or in some way directed OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="59">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ could modify or in some way direct OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="60">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ could significantly modify or in some way direct OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="61">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ has modified or in some way directed OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="62">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ has significantly modified or in some way directed OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="63">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ has the ability to modify or in some way direct OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="64">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ has the ability to significantly modify or in some way direct OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="65">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ has the probability of modifying or in some way directing OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="66">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ has the probability of significantly modifying or in some way directing OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="67">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ is able to modify or in some way direct OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="68">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ is able to significantly modify or in some way direct OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="69">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ is modifying or in some way directing OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="70">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ is observed to modify or in some way direct OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="71">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ is observed to significantly modify or in some way direct OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="72">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ is significantly modifying or in some way directing OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="73">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ may have modified or in some way directed OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="74">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ may have significantly modified or in some way directed OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="75">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ may modify or in some way direct OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="76">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ may significantly modify or in some way direct OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="77">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ might have modified or in some way directed OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="78">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ might have significantly modified or in some way directed OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="79">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ modified or in some way directed OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="80">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ modifies or in some way directs OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="81">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ significantly modified or in some way directed OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="82">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ significantly modifies or in some way directs OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="83">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ will modify or in some way direct OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="84">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ will significantly modify or in some way direct OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="85">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ would modify or in some way direct OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="86">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., EnvZ would significantly modify or in some way direct OmpR, which in turn acts at the appropriate porin gene promoter.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                    <arg n="3">acts at the appropriate porin gene promoter</arg>
                </example>
                <example src="ARCHIVE" no="87">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., OmpR, which acts at the appropriate porin gene promoter, can be modified or in some way directed by EnvZ.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="ARCHIVE" no="88">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., OmpR, which acts at the appropriate porin gene promoter, can be significantly modified or in some way directed by EnvZ.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="ARCHIVE" no="89">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., OmpR, which acts at the appropriate porin gene promoter, could have been modified or in some way directed by EnvZ.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="ARCHIVE" no="90">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., OmpR, which acts at the appropriate porin gene promoter, could have been significantly modified or in some way directed by EnvZ.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="ARCHIVE" no="91">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., OmpR, which acts at the appropriate porin gene promoter, has been modified or in some way directed by EnvZ.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="ARCHIVE" no="92">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., OmpR, which acts at the appropriate porin gene promoter, has been significantly modified or in some way directed by EnvZ.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="ARCHIVE" no="93">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., OmpR, which acts at the appropriate porin gene promoter, has the ability to be modified or in some way directed by EnvZ.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="ARCHIVE" no="94">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., OmpR, which acts at the appropriate porin gene promoter, has the ability to be significantly modified or in some way directed by EnvZ.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="ARCHIVE" no="95">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., OmpR, which acts at the appropriate porin gene promoter, has the probability of being modified or in some way directed by EnvZ.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="ARCHIVE" no="96">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., OmpR, which acts at the appropriate porin gene promoter, has the probability of being significantly modified or in some way directed by EnvZ.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="ARCHIVE" no="97">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., OmpR, which acts at the appropriate porin gene promoter, is able to be modified or in some way directed by EnvZ.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="ARCHIVE" no="98">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., OmpR, which acts at the appropriate porin gene promoter, is able to be significantly modified or in some way directed by EnvZ.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="ARCHIVE" no="99">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., OmpR, which acts at the appropriate porin gene promoter, is modified or in some way directed by EnvZ.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="ARCHIVE" no="100">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., OmpR, which acts at the appropriate porin gene promoter, is observed to be modified or in some way directed by EnvZ.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="ARCHIVE" no="101">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., OmpR, which acts at the appropriate porin gene promoter, is observed to be significantly modified or in some way directed by EnvZ.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="ARCHIVE" no="102">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., OmpR, which acts at the appropriate porin gene promoter, is significantly modified or in some way directed by EnvZ.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="ARCHIVE" no="103">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., OmpR, which acts at the appropriate porin gene promoter, may be modified or in some way directed by EnvZ.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="ARCHIVE" no="104">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., OmpR, which acts at the appropriate porin gene promoter, may be significantly modified or in some way directed by EnvZ.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="ARCHIVE" no="105">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., OmpR, which acts at the appropriate porin gene promoter, may have been modified or in some way directed by EnvZ.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="ARCHIVE" no="106">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., OmpR, which acts at the appropriate porin gene promoter, may have been significantly modified or in some way directed by EnvZ.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="ARCHIVE" no="107">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., OmpR, which acts at the appropriate porin gene promoter, was modified or in some way directed by EnvZ.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="ARCHIVE" no="108">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., OmpR, which acts at the appropriate porin gene promoter, was significantly modified or in some way directed by EnvZ.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="ARCHIVE" no="109">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., OmpR, which acts at the appropriate porin gene promoter, will be modified or in some way directed by EnvZ.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="ARCHIVE" no="110">
                    <text>These results lead us to conclude that EnvZ and OmpR act in sequential fashion to activate porin gene expression; i.e., OmpR, which acts at the appropriate porin gene promoter, will be significantly modified or in some way directed by EnvZ.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="ARCHIVE" no="111">
                    <text>To define the subcellular location of HVDAC isoforms, HVDAC genes are able to be modified so that the encoded proteins contain COOH-terminal epitopes recognized by either of two monoclonal antibodies.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="ARCHIVE" no="112">
                    <text>To define the subcellular location of HVDAC isoforms, HVDAC genes are able to be remarkably modified so that the encoded proteins contain COOH-terminal epitopes recognized by either of two monoclonal antibodies.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="ARCHIVE" no="113">
                    <text>To define the subcellular location of HVDAC isoforms, HVDAC genes are modified so that the encoded proteins contain COOH-terminal epitopes recognized by either of two monoclonal antibodies.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="ARCHIVE" no="114">
                    <text>To define the subcellular location of HVDAC isoforms, HVDAC genes are observed to be modified so that the encoded proteins contain COOH-terminal epitopes recognized by either of two monoclonal antibodies.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="ARCHIVE" no="115">
                    <text>To define the subcellular location of HVDAC isoforms, HVDAC genes are observed to be remarkably modified so that the encoded proteins contain COOH-terminal epitopes recognized by either of two monoclonal antibodies.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="ARCHIVE" no="116">
                    <text>To define the subcellular location of HVDAC isoforms, HVDAC genes are remarkably modified so that the encoded proteins contain COOH-terminal epitopes recognized by either of two monoclonal antibodies.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="ARCHIVE" no="117">
                    <text>To define the subcellular location of HVDAC isoforms, HVDAC genes can be modified so that the encoded proteins contain COOH-terminal epitopes recognized by either of two monoclonal antibodies.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="ARCHIVE" no="118">
                    <text>To define the subcellular location of HVDAC isoforms, HVDAC genes can be remarkably modified so that the encoded proteins contain COOH-terminal epitopes recognized by either of two monoclonal antibodies.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="ARCHIVE" no="119">
                    <text>To define the subcellular location of HVDAC isoforms, HVDAC genes could have been modified so that the encoded proteins contain COOH-terminal epitopes recognized by either of two monoclonal antibodies.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="ARCHIVE" no="120">
                    <text>To define the subcellular location of HVDAC isoforms, HVDAC genes could have been remarkably modified so that the encoded proteins contain COOH-terminal epitopes recognized by either of two monoclonal antibodies.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="ARCHIVE" no="121">
                    <text>To define the subcellular location of HVDAC isoforms, HVDAC genes have been modified so that the encoded proteins contain COOH-terminal epitopes recognized by either of two monoclonal antibodies.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="ARCHIVE" no="122">
                    <text>To define the subcellular location of HVDAC isoforms, HVDAC genes have been remarkably modified so that the encoded proteins contain COOH-terminal epitopes recognized by either of two monoclonal antibodies.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="ARCHIVE" no="123">
                    <text>To define the subcellular location of HVDAC isoforms, HVDAC genes have the ability to be modified so that the encoded proteins contain COOH-terminal epitopes recognized by either of two monoclonal antibodies.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="ARCHIVE" no="124">
                    <text>To define the subcellular location of HVDAC isoforms, HVDAC genes have the ability to be remarkably modified so that the encoded proteins contain COOH-terminal epitopes recognized by either of two monoclonal antibodies.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="ARCHIVE" no="125">
                    <text>To define the subcellular location of HVDAC isoforms, HVDAC genes may be modified so that the encoded proteins contain COOH-terminal epitopes recognized by either of two monoclonal antibodies.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="ARCHIVE" no="126">
                    <text>To define the subcellular location of HVDAC isoforms, HVDAC genes may be remarkably modified so that the encoded proteins contain COOH-terminal epitopes recognized by either of two monoclonal antibodies.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="ARCHIVE" no="127">
                    <text>To define the subcellular location of HVDAC isoforms, HVDAC genes might have been modified so that the encoded proteins contain COOH-terminal epitopes recognized by either of two monoclonal antibodies.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="ARCHIVE" no="128">
                    <text>To define the subcellular location of HVDAC isoforms, HVDAC genes might have been remarkably modified so that the encoded proteins contain COOH-terminal epitopes recognized by either of two monoclonal antibodies.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="ARCHIVE" no="129">
                    <text>To define the subcellular location of HVDAC isoforms, HVDAC genes were modified so that the encoded proteins contain COOH-terminal epitopes recognized by either of two monoclonal antibodies.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="ARCHIVE" no="130">
                    <text>To define the subcellular location of HVDAC isoforms, HVDAC genes will be modified so that the encoded proteins contain COOH-terminal epitopes recognized by either of two monoclonal antibodies.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="ARCHIVE" no="131">
                    <text>To define the subcellular location of HVDAC isoforms, HVDAC genes will be remarkably modified so that the encoded proteins contain COOH-terminal epitopes recognized by either of two monoclonal antibodies.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="ARCHIVE" no="132">
                    <text>We are able to modify P.falciparum genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="133">
                    <text>We are able to notably modify P.falciparum genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="134">
                    <text>We can modify P.falciparum genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="135">
                    <text>We can notably modify P.falciparum genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="136">
                    <text>We have modified P.falciparum genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="137">
                    <text>We have notably modified P.falciparum genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="138">
                    <text>We have the ability to modify P.falciparum genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="139">
                    <text>We have the ability to notably modify P.falciparum genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="140">
                    <text>We have used the ability to modify P.falciparum genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="141">
                    <text>We may modify P.falciparum genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="142">
                    <text>We may notably modify P.falciparum genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="143">
                    <text>We modified P.falciparum genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="144">
                    <text>We modify P.falciparum genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="145">
                    <text>We notably modified P.falciparum genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="146">
                    <text>We notably modify P.falciparum genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="147">
                    <text>We will modify P.falciparum genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="ARCHIVE" no="148">
                    <text>We will notably modify P.falciparum genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which being apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which being modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which are able to be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which are able to be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which are observed to be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which are observed to be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which can be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which can be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which have been apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which have been modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which have the ability to be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which have the ability to be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which may be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which may be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which might have been apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which might have been modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which were apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which were modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which will be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which will be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 subunits, subunits are apparently modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III are able to be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III are able to be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III are apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III are modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III are observed to be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III are observed to be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III can be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III can be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III have been apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III have been modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III have the ability to be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III have the ability to be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III may be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III may be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III might have been apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III might have been modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III were apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III were modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III will be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III will be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests factors that has the probability of modifing the the binding of either U5 or SH3.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests factors which has the probability of modifing the the binding of either U5 or SH3.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>The the binding of either U5 or SH3 can be actually modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>The the binding of either U5 or SH3 can be modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>The the binding of either U5 or SH3 has been actually modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>The the binding of either U5 or SH3 has been modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>The the binding of either U5 or SH3 has the ability to be actually modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>The the binding of either U5 or SH3 has the ability to be modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="52">
                    <text>The the binding of either U5 or SH3 has the probability of being actually modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="53">
                    <text>The the binding of either U5 or SH3 has the probability of being modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="54">
                    <text>The the binding of either U5 or SH3 is able to be actually modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="55">
                    <text>The the binding of either U5 or SH3 is able to be modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="56">
                    <text>The the binding of either U5 or SH3 is actually modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="57">
                    <text>The the binding of either U5 or SH3 is modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="58">
                    <text>The the binding of either U5 or SH3 is observed to be actually modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="59">
                    <text>The the binding of either U5 or SH3 is observed to be modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="60">
                    <text>The the binding of either U5 or SH3 may be actually modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="61">
                    <text>The the binding of either U5 or SH3 may be modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="62">
                    <text>The the binding of either U5 or SH3 might be actually modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="63">
                    <text>The the binding of either U5 or SH3 might be modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="64">
                    <text>The the binding of either U5 or SH3 was actually modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="65">
                    <text>The the binding of either U5 or SH3 was modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="66">
                    <text>The the binding of either U5 or SH3 will be actually modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="67">
                    <text>The the binding of either U5 or SH3 will be modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes being apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes being modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which are able to be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which are able to be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which are observed to be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which are observed to be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which can be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which can be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which have been apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which have been modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which have the ability to be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which have the ability to be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which may be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which may be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which might have been apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which might have been modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which were apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which were modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which will be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which will be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, subunits are apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III are able to be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III are able to be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III are apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III are modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III are observed to be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III are observed to be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III can be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III can be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III have been apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III have been modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III have the ability to be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III have the ability to be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III may be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III may be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III might have been apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III might have been modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III were apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III were modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III will be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III will be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests EnvZ that has the probability of modifing the OmpR.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="45">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests EnvZ which has the probability of modifing the OmpR.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="46">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests We that has the probability of modifing the P.falciparum.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="47">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests We which has the probability of modifing the P.falciparum.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="48">
                    <text>The OmpR can be actually modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="49">
                    <text>The OmpR can be modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="50">
                    <text>The OmpR has been actually modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="51">
                    <text>The OmpR has been modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="52">
                    <text>The OmpR has the ability to be actually modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="53">
                    <text>The OmpR has the ability to be modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="54">
                    <text>The OmpR has the probability of being actually modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="55">
                    <text>The OmpR has the probability of being modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="56">
                    <text>The OmpR is able to be actually modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="57">
                    <text>The OmpR is able to be modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="58">
                    <text>The OmpR is actually modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="59">
                    <text>The OmpR is modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="60">
                    <text>The OmpR is observed to be actually modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="61">
                    <text>The OmpR is observed to be modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="62">
                    <text>The OmpR may be actually modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="63">
                    <text>The OmpR may be modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="64">
                    <text>The OmpR might be actually modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="65">
                    <text>The OmpR might be modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="66">
                    <text>The OmpR was actually modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="67">
                    <text>The OmpR was modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="68">
                    <text>The OmpR will be actually modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="69">
                    <text>The OmpR will be modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="70">
                    <text>The P.falciparum can be actually modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="71">
                    <text>The P.falciparum can be modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="72">
                    <text>The P.falciparum has been actually modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="73">
                    <text>The P.falciparum has been modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="74">
                    <text>The P.falciparum has the ability to be actually modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="75">
                    <text>The P.falciparum has the ability to be modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="76">
                    <text>The P.falciparum has the probability of being actually modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="77">
                    <text>The P.falciparum has the probability of being modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="78">
                    <text>The P.falciparum is able to be actually modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="79">
                    <text>The P.falciparum is able to be modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="80">
                    <text>The P.falciparum is actually modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="81">
                    <text>The P.falciparum is modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="82">
                    <text>The P.falciparum is observed to be actually modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="83">
                    <text>The P.falciparum is observed to be modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="84">
                    <text>The P.falciparum may be actually modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="85">
                    <text>The P.falciparum may be modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="86">
                    <text>The P.falciparum might be actually modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="87">
                    <text>The P.falciparum might be modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="88">
                    <text>The P.falciparum was actually modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="89">
                    <text>The P.falciparum was modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="90">
                    <text>The P.falciparum will be actually modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="91">
                    <text>The P.falciparum will be modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="SEED" no="1">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 subunits apparently modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="2">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 subunits being apparently modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="3">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 subunits being modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="4">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 subunits modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="5">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 subunits, some of which are able to be apparently modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="6">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 subunits, some of which are able to be modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="7">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 subunits, some of which are apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="SEED" no="8">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 subunits, some of which are observed to be apparently modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="9">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 subunits, some of which are observed to be modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="10">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 subunits, some of which can be apparently modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="11">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 subunits, some of which can be modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="12">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 subunits, some of which have been apparently modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="13">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 subunits, some of which have been modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="14">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 subunits, some of which have the ability to be apparently modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="15">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 subunits, some of which have the ability to be modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="16">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 subunits, some of which may be apparently modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="17">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 subunits, some of which may be modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="18">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 subunits, some of which might have been apparently modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="19">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 subunits, some of which might have been modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="20">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 subunits, some of which were apparently modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="21">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 subunits, some of which were modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="22">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 subunits, some of which will be apparently modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="23">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 subunits, some of which will be modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="24">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human RNA Pol III are able to be apparently modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="25">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human RNA Pol III are able to be modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="26">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human RNA Pol III are apparently modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="27">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human RNA Pol III are modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="28">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human RNA Pol III are observed to be apparently modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="29">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human RNA Pol III are observed to be modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="30">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human RNA Pol III can be apparently modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="31">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human RNA Pol III can be modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="32">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human RNA Pol III have been apparently modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="33">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human RNA Pol III have been modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="34">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human RNA Pol III have the ability to be apparently modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="35">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human RNA Pol III have the ability to be modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="36">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human RNA Pol III may be apparently modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="37">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human RNA Pol III may be modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="38">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human RNA Pol III might have been apparently modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="39">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human RNA Pol III might have been modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="40">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human RNA Pol III were apparently modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="41">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human RNA Pol III were modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="42">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human RNA Pol III will be apparently modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="43">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human RNA Pol III will be modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="SEED" no="44">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests a potential mechanism that has the probability of modifing the EZH1 protein in the conserved C-terminal domain.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="SEED" no="45">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests a potential mechanism which has the probability of modifing the EZH1 protein in the conserved C-terminal domain.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="SEED" no="46">
                    <text>Taken together these data suggest that the SH3 acts to position the U5 region through its own association with the GUK domain and that factors that can modify the binding of either U5 or SH3 to the GUK domain may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="47">
                    <text>Taken together these data suggest that the SH3 acts to position the U5 region through its own association with the GUK domain and that factors which are able to modify the binding of either U5 or SH3 to the GUK domain may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="48">
                    <text>Taken together these data suggest that the SH3 acts to position the U5 region through its own association with the GUK domain and that factors which are observed to modify the binding of either U5 or SH3 to the GUK domain may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="49">
                    <text>Taken together these data suggest that the SH3 acts to position the U5 region through its own association with the GUK domain and that factors which can modify the binding of either U5 or SH3 to the GUK domain may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="50">
                    <text>Taken together these data suggest that the SH3 acts to position the U5 region through its own association with the GUK domain and that factors which have modified the binding of either U5 or SH3 to the GUK domain may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="51">
                    <text>Taken together these data suggest that the SH3 acts to position the U5 region through its own association with the GUK domain and that factors which have the ability to modify the binding of either U5 or SH3 to the GUK domain may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="52">
                    <text>Taken together these data suggest that the SH3 acts to position the U5 region through its own association with the GUK domain and that factors which have the probability of modifying the binding of either U5 or SH3 to the GUK domain may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="53">
                    <text>Taken together these data suggest that the SH3 acts to position the U5 region through its own association with the GUK domain and that factors which may modify the binding of either U5 or SH3 to the GUK domain may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="54">
                    <text>Taken together these data suggest that the SH3 acts to position the U5 region through its own association with the GUK domain and that factors which might have modified the binding of either U5 or SH3 to the GUK domain may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="55">
                    <text>Taken together these data suggest that the SH3 acts to position the U5 region through its own association with the GUK domain and that factors which modified the binding of either U5 or SH3 to the GUK domain may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="56">
                    <text>Taken together these data suggest that the SH3 acts to position the U5 region through its own association with the GUK domain and that factors which modify the binding of either U5 or SH3 to the GUK domain may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="57">
                    <text>Taken together these data suggest that the SH3 acts to position the U5 region through its own association with the GUK domain and that factors which will modify the binding of either U5 or SH3 to the GUK domain may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="58">
                    <text>Taken together these data suggest that the binding of either U5 or SH3 to the GUK domain can be modified by factors that may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="59">
                    <text>Taken together these data suggest that the binding of either U5 or SH3 to the GUK domain could be modified by factors that may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="60">
                    <text>Taken together these data suggest that the binding of either U5 or SH3 to the GUK domain could have been modified by factors that may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="61">
                    <text>Taken together these data suggest that the binding of either U5 or SH3 to the GUK domain has been observed to be modified by factors that may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="62">
                    <text>Taken together these data suggest that the binding of either U5 or SH3 to the GUK domain has the ability to be modified by factors that may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="63">
                    <text>Taken together these data suggest that the binding of either U5 or SH3 to the GUK domain has the probability of being modified by factors that may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="64">
                    <text>Taken together these data suggest that the binding of either U5 or SH3 to the GUK domain is able to be modified by factors that may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="65">
                    <text>Taken together these data suggest that the binding of either U5 or SH3 to the GUK domain is observed to be modified by factors that may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="66">
                    <text>Taken together these data suggest that the binding of either U5 or SH3 to the GUK domain may be modified by factors that may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="67">
                    <text>Taken together these data suggest that the binding of either U5 or SH3 to the GUK domain may have been modified by factors that may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="68">
                    <text>Taken together these data suggest that the binding of either U5 or SH3 to the GUK domain might be modified by factors that may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="69">
                    <text>Taken together these data suggest that the binding of either U5 or SH3 to the GUK domain might have been modified by factors that may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="70">
                    <text>Taken together these data suggest that the binding of either U5 or SH3 to the GUK domain was able to be modified by factors that may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="71">
                    <text>Taken together these data suggest that the binding of either U5 or SH3 to the GUK domain was modified by factors that may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="72">
                    <text>Taken together these data suggest that the binding of either U5 or SH3 to the GUK domain was observed to be modified by factors that may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="73">
                    <text>Taken together these data suggest that the binding of either U5 or SH3 to the GUK domain will be modified by factors that may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="74">
                    <text>Taken together these data suggest that the binding of either U5 or SH3 to the GUK domain would have been modified by factors that may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="SEED" no="75">
                    <text>The EZH1 protein in the conserved C-terminal domain can be actually modified by a potential mechanism suggested by analysis of one cDNA.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="SEED" no="76">
                    <text>The EZH1 protein in the conserved C-terminal domain can be modified by a potential mechanism suggested by analysis of one cDNA.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="SEED" no="77">
                    <text>The EZH1 protein in the conserved C-terminal domain has been actually modified by a potential mechanism suggested by analysis of one cDNA.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="SEED" no="78">
                    <text>The EZH1 protein in the conserved C-terminal domain has been modified by a potential mechanism suggested by analysis of one cDNA.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="SEED" no="79">
                    <text>The EZH1 protein in the conserved C-terminal domain has the ability to be actually modified by a potential mechanism suggested by analysis of one cDNA.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="SEED" no="80">
                    <text>The EZH1 protein in the conserved C-terminal domain has the ability to be modified by a potential mechanism suggested by analysis of one cDNA.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="SEED" no="81">
                    <text>The EZH1 protein in the conserved C-terminal domain has the probability of being actually modified by a potential mechanism suggested by analysis of one cDNA.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="SEED" no="82">
                    <text>The EZH1 protein in the conserved C-terminal domain has the probability of being modified by a potential mechanism suggested by analysis of one cDNA.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="SEED" no="83">
                    <text>The EZH1 protein in the conserved C-terminal domain is able to be actually modified by a potential mechanism suggested by analysis of one cDNA.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="SEED" no="84">
                    <text>The EZH1 protein in the conserved C-terminal domain is able to be modified by a potential mechanism suggested by analysis of one cDNA.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="SEED" no="85">
                    <text>The EZH1 protein in the conserved C-terminal domain is actually modified by a potential mechanism suggested by analysis of one cDNA.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="SEED" no="86">
                    <text>The EZH1 protein in the conserved C-terminal domain is modified by a potential mechanism suggested by analysis of one cDNA.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="SEED" no="87">
                    <text>The EZH1 protein in the conserved C-terminal domain is observed to be actually modified by a potential mechanism suggested by analysis of one cDNA.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="SEED" no="88">
                    <text>The EZH1 protein in the conserved C-terminal domain is observed to be modified by a potential mechanism suggested by analysis of one cDNA.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="SEED" no="89">
                    <text>The EZH1 protein in the conserved C-terminal domain may be actually modified by a potential mechanism suggested by analysis of one cDNA.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="SEED" no="90">
                    <text>The EZH1 protein in the conserved C-terminal domain may be modified by a potential mechanism suggested by analysis of one cDNA.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="SEED" no="91">
                    <text>The EZH1 protein in the conserved C-terminal domain might be actually modified by a potential mechanism suggested by analysis of one cDNA.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="SEED" no="92">
                    <text>The EZH1 protein in the conserved C-terminal domain might be modified by a potential mechanism suggested by analysis of one cDNA.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="SEED" no="93">
                    <text>The EZH1 protein in the conserved C-terminal domain was actually modified by a potential mechanism suggested by analysis of one cDNA.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="SEED" no="94">
                    <text>The EZH1 protein in the conserved C-terminal domain was modified by a potential mechanism suggested by analysis of one cDNA.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="SEED" no="95">
                    <text>The EZH1 protein in the conserved C-terminal domain will be actually modified by a potential mechanism suggested by analysis of one cDNA.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
                <example src="SEED" no="96">
                    <text>The EZH1 protein in the conserved C-terminal domain will be modified by a potential mechanism suggested by analysis of one cDNA.</text>
                    <arg n="0">a potential mechanism</arg>
                    <arg n="1">EZH1 protein in the conserved C-terminal domain</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
